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a  b  s  t  r  a  c  t
Bioﬁlm-associated  bacteria  display  a decreased  susceptibility  towards  antibiotics.  Routine  assessment  of
antibiotic  susceptibility  of  planktonic  bacteria  therefore  offers  an  insufﬁcient  prediction  of  the bioﬁlm
response.  In  this  study,  in  vitro  bioﬁlms  of eight  clinical  Staphylococcus  epidermidis  strains  were sub-
jected  to treatment  with  vancomycin,  teicoplanin,  oxacillin,  rifampicin  and gentamicin.  In addition,  the
bioﬁlms  were  subjected  to  combinations  of an  antibiotic  with  rifampicin.  The  effects  on  the  bioﬁlms  were
assessed  by  crystal  violet  staining  to  determine  the  total  bioﬁlm  biomass,  staining  with  XTT  to determine
bacterial  cell  viability,  and  microscopy.  Combining  these  methods  showed  that  treatment  of  S. epider-
midis  bioﬁlms  with  glycopeptides  increased  the  total  bioﬁlm  biomass  and  that  these  antibiotics  were  not
effective  in  killing  bacteria  embedded  in  bioﬁlms.  The  decreased  killing  efﬁcacy  was  more  pronounced  in
bioﬁlms  produced  by  strains  that  were  classiﬁed  as ‘strong’  bioﬁlm  producers.  Rifampicin,  oxacillin  and
gentamicin  effectively  killed  bioﬁlm-associated  bacteria  of  all tested strains.  Combining  antibiotics  with
rifampicin  increased  the  killing  efﬁcacy  without  inﬂuencing  the  total  bioﬁlm  biomass.  When  vancomycin
or  teicoplanin  were  combined  with  rifampicin,  the  increase  in  bioﬁlm  biomass  was  neutralised  and  also
the killing  efﬁcacy  was  inﬂuenced  in  a  positive  way.  We  conclude  that  the combined  methodology  used
in  this  study  showed  that  glycopeptides  were  not  effective  in  eradicating  S. epidermidis  bioﬁlms  but that
combination  with  rifampicin  improved  the  killing  efﬁcacy  in vitro.
© 2015  Elsevier  B.V.  and  the  International  Society  of  Chemotherapy.  All  rights  reserved.. Introduction
Determination of the minimum inhibitory concentration (MIC)
f an antibiotic is the standard method to determine bacterial
usceptibility towards antibiotics. This method is based on the inhi-
ition of planktonic growth of bacteria. However, in many types
f infections, bacteria with a sessile lifestyle resulting in bioﬁlms
re involved [1,2]. A bioﬁlm is deﬁned as a multicellular aggre-
ate of micro-organisms attached to a surface and embedded in a
elf-produced extracellular matrix. Bacteria growing in bioﬁlms arePlease cite this article in press as: Claessens J, et al. Inefﬁcacy of vanc
epidermidis bioﬁlms in vitro. Int J Antimicrob Agents (2015), http://dx
haracterised by increased resistance towards antibiotics and the
ost’s immune response [2]. This is attributed to: (i) a different phe-
otype of bacteria growing in a bioﬁlm compared with planktonic
∗ Corresponding author. Tel.: +32 16 346 274; fax: +32 16 346 275.
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J. Claessens).
ttp://dx.doi.org/10.1016/j.ijantimicag.2014.11.011
924-8579/© 2015 Elsevier B.V. and the International Society of Chemotherapy. All rightsbacteria, with decreased activity of the basic metabolic pathways
and increased expression of stress response genes [3]; (ii) the extra-
cellular matrix, which creates a micro-environment that interferes
with antibiotic activity by decreasing penetration of the antibiotic,
sequestering it or by the presence of modifying enzymes [4]; and
(iii) the facilitated exchange of antibiotic resistance genes when
bacteria are growing in high numbers close to each other [5].
Because of the decreased sensitivity of bioﬁlm-associated bacte-
ria to antibiotics, methods to evaluate antibiotic susceptibility
should, in the case of bioﬁlm-related infections, be supplemented
with tests conducted on in vitro bioﬁlms [6]. Different methods
have been proposed to do this, including determination of the mini-
mum antibiotic concentrations that inhibit bioﬁlm growth (bioﬁlm
MIC), reduce the bacterial load of the bioﬁlm [bioﬁlm minimumomycin and teicoplanin in eradicating and killing Staphylococcus
.doi.org/10.1016/j.ijantimicag.2014.11.011
bactericidal concentration (MBC)] or completely eradicate the
bioﬁlm [minimum bioﬁlm eradication concentration (MBEC)] [7].
However, the resulting antibiotic concentrations exceeded physio-
logically achievable concentrations [7]. Another way to determine
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ntibiotic response consists of assessing the effects on the bacterial
iability and the extracellular matrix separately [6]. In the present
tudy, the effects of antibiotics on in vitro Staphylococcus epider-
idis bioﬁlms were evaluated using XTT staining as a measure for
acterial viability [8] and crystal violet (CV) to determine the total
ioﬁlm biomass [9]. These methods were combined with micro-
copic techniques to visualise the observed effects. The applied
ntibiotic concentrations corresponded to the peak serum concen-
rations, which is different from previously published studies that
sed subinhibitory antibiotic concentrations [10,11].
. Materials and methods
.1. Bacterial strains and growth conditions
Table 1 summarises the S. epidermidis strains used in this
tudy. All strains, except S. epidermidis 567, were isolated from
loodstream infections associated with central venous catheters
CVCs). S. epidermidis 567 was isolated from a urinary tract catheter
nfection; this strain was kindly provided by Prof. Dr W.  Ziebuhr
University of Würzburg, Würzburg, Germany) [12]. S. epidermidis
457 is a type strain often used in bioﬁlm research [13], and S.
pidermidis 10b was isolated from a conﬁrmed case of catheter
nfection in the University Hospital Leuven (Belgium) [14]. In
ddition to the laboratory strains, clinical isolates from proven
ioﬁlm-related infections were used. These strains are designated
. epidermidis 12c, 13c, 16c, 17c and 22c (Table 1).
Tryptone soya broth (TSB) (Oxoid Ltd., Basingstoke, UK) was
repared according to the manufacturer’s instructions. Growth
onditions were adjusted to optimise bioﬁlm formation and detec-
ion (Table 1). Because of the high bioﬁlm formation capacities of
. epidermidis 1457, 10b and 22c, bioﬁlm formation of these strains
as allowed to occur in 10% TSB in phosphate-buffered saline (PBS)
pH 7.2). This was done to adjust the total bioﬁlm biomass to the
pper detection limit of the enzyme-linked immunosorbent assay
ELISA) reader (VICTOR3TM Multilabel Plate Reader; PerkinElmer
ingapore Pte Ltd., Singapore). S. epidermidis 567 was  characterised
s a bioﬁlm-negative, ica-positive strain; bioﬁlm formation was
nduced by adding 4% NaCl to the culture medium [15].
The antibiotics used to treat the bioﬁlms were all purchased
rom Sigma-Aldrich Chemie GmbH (Steinheim, Germany). Antibi-
tic stock solutions, except rifampicin, were prepared in sterilised
illi-Q® water (Merck Millipore, Carrigtwohill, Ireland) and were
ept at −20 ◦C. The rifampicin stock was prepared in methanol and
ere kept at −20 ◦C.
.2. Minimum inhibitory concentration determination
The MICs of antibiotics towards planktonic bacteria were deter-
ined by the broth dilution method according to the European
ommittee on Antimicrobial Susceptibility Testing (EUCAST) [16].
acterial growth was assessed by measurement of the optical den-
ity at 590 nm using a VICTOR3TM Multilabel Plate Reader.
.3. In vitro bioﬁlm formation and treatment with antibiotics
Starting from overnight cultures on blood agar plates, several
olonies were re-suspended in saline (0.9% w/v NaCl) to reach an
ptical density equal to 0.5 McFarland standard (Cobas Inocheck;
oche Diagnostics GmbH, Mannheim, Germany). This suspension
as diluted 100 times in the appropriate growth medium used for
ioﬁlm formation (Table 1). Then, 200 L of the bacterial suspen-Please cite this article in press as: Claessens J, et al. Inefﬁcacy of vanc
epidermidis bioﬁlms in vitro. Int J Antimicrob Agents (2015), http://dx
ion was applied to each well of a ﬂat-bottomed 96-well microtitre
late (Cellstar®; Greiner Bio-One, Frickenhausen, Germany). Plates
ere incubated statically for 24 h at 37 ◦C. Subsequently, the super-
atants were discarded and the formed bioﬁlms were washed once PRESS
timicrobial Agents xxx (2015) xxx–xxx
with 250 L of PBS. Bioﬁlms were treated with 200 L of antibiotic
solution (in 1% TSB, i.e. 100 times diluted in PBS) for 24 h at 37 ◦C.
The applied concentrations of the antibiotics were 40 g/mL for
vancomycin, 50 g/mL for teicoplanin, and 10 g/mL for oxacillin,
rifampicin and gentamicin.
2.4. Evaluation of the bioﬁlms
The supernatants were discarded and the bioﬁlms were washed
twice with 250 L of PBS. The plates were stained with CV accord-
ing to the method proposed by Stepanovic´  et al. [9]. After ﬁxing
the bioﬁlms with ethanol (96%), the plates were dried and stained
for 15 min  with 230 L of Hucker’s CV solution [0.5 mg  CV (Sigma-
Aldrich) dissolved in 5 mL  of ethanol 100%, and combined with
45 mL  of an aqueous solution containing 1% ammonium oxalate
(Sigma-Aldrich)]. The plates were washed to remove excess stain
and were subsequently dried. Bound CV was  eluted by adding
200 L of 5% acetic acid to each well. After 30 min  of incubation at
room temperature, 150 L of the eluate was transferred to a new
96-well plate and the absorbance of the eluate was measured at
590 nm using a VICTOR3TM Multilabel Plate Reader.
For staining bioﬁlms with XTT, the method described by Cerca
et al. [8] was used. The XTT solution (0.2 mg/mL XTT, 0.02 mg/mL
phenazine methosulphate; Sigma-Aldrich) was prepared in 1% TSB,
and incubation of the bioﬁlms with the staining solution lasted for
2 h at 37 ◦C in the dark. Absorbance of the supernatant was mea-
sured at 490 nm using a VICTOR3TM Multilabel Plate Reader.
The results after antibiotic treatment of the bioﬁlms were
expressed relative to the staining result after treatment of the
bioﬁlm with the negative control (1% TSB).
2.5. Scanning electron microscopy (SEM)
Bioﬁlms were grown on glass coverslip disks (13 mm diame-
ter; Assistent, Glaswarenfabrik Karl Hecht, Sondheim, Germany)
for 24 h and were treated with antibiotics as mentioned pre-
viously. Bioﬁlms on the coverslip disks were rinsed once with
1 mL  of PBS and were ﬁxed for 2 h with glutaraldehyde (2.5%) in
sodium cacodylate buffer (0.1 M,  pH 7.4) at room temperature.
Afterwards, bioﬁlms were washed with sodium cacodylate buffer
and post-ﬁxed for 2 h with osmium tetroxide (1% in Milli-Q water)
at 4 ◦C, protected from light. The ﬁxed samples were dehydrated
with ethanol in ascending concentrations [30–50–70–90% (v/v)]
for 5 min  and 100% (v/v) ethanol for 3 × 5 min. For the ﬁnal dehy-
dration step, hexamethyldisilazane (HMDS) (Sigma-Aldrich) was
used for 2 × 15 min. After overnight drying in a vacuum desiccator,
the samples were sputter-coated with platinum for 120 s (Auto-
matic sputter coater; Agar Scientiﬁc, Elektron Technology UK Ltd.,
Stansted, UK). Imaging was  conducted on a JSM 7401F scanning
electron microscope (JEOL, Tokyo, Japan). In each sample, three dif-
ferent areas were observed at magniﬁcations of 1000×, 4000× and
10 000×.
2.6. Statistical analysis
Data were processed with Microsoft Excel (Microsoft Corp., Red-
mond, WA)  and statistical analysis was  conducted with IBM SPSS
Statistics for Windows v.22.0 (IBM Corp., Armonk, NY). Differences
between treatments were analysed by one-way analysis of vari-
ance (ANOVA), and differences between strains were characterised
by two-way ANOVA. ANOVA analysis assumes that the data haveomycin and teicoplanin in eradicating and killing Staphylococcus
.doi.org/10.1016/j.ijantimicag.2014.11.011
a normal distribution and equal variances. Normality of the data
was tested with the Shapiro–Wilk test and evaluation of the Q–Q
plots. Equality of variances was  analysed with the Levene’s test. If
the variances were not equal, Welch ANOVA analysis was  applied.
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Table  1
Staphylococcus epidermidis strains used in the study.
Strain Description Bioﬁlm growth conditions Reference
10b Clinical isolate; catheter-related BSI 10% TSB UZ Leuven [14]
1457 Clinical isolate; catheter-related BSI 10% TSB [13]
567 Clinical isolate; urinary tract catheter-related infection TSB + 4% NaCl [12]
12c Clinical isolate; CVC subcutaneous section TSB UZ Leuven
13c  Clinical isolate; CVC catheter tip TSB UZ Leuven
16c  Clinical isolate; CVC catheter tip TSB UZ Leuven
17c  Clinical isolate; CVC subcutaneous section TSB UZ Leuven
22c  Clinical isolate; CVC catheter tip 
BSI, bloodstream infection; TSB, tryptone soya broth; CVC, central venous catheter.
Table 2
Overview of minimum inhibitory concentrations (MICs) of planktonic cells of
selected Staphylococcus epidermidis strains.
Strain MIC  (g/mL) (sensitivitya)
VAN TEI OXA RIF GEN
567 2 (S) 1 (S) 0.25 (S) 0.25 (S) 0.25 (S)
1457  1 (S) 4 (S) 0.25 (S) 0.25 (S) 0.25 (S)
10b  1 (S) 4 (S) 0.25 (S) 0.25 (S) 1 (S)
















a Determined following European Committee on Antimicrobial Susceptibility
esting (EUCAST) clinical breakpoints for staphylococci.
When the ANOVA analysis was signiﬁcant, and the differences
etween the tested groups were signiﬁcant, multiple t-tests were
onducted to locate the differences. To correct for multiple testing,
he signiﬁcance level was adjusted according to Sˇídák. Overall, a
igniﬁcance level of P < 0.05 was presumed.
. Results
.1. Minimum inhibitory concentrationsPlease cite this article in press as: Claessens J, et al. Inefﬁcacy of vanc
epidermidis bioﬁlms in vitro. Int J Antimicrob Agents (2015), http://dx
For S. epidermidis strains 567, 1457 and 10b, antibi-
tic susceptibilities were determined according the EUCAST
uidelines (Table 2). According to EUCAST breakpoints
http://www.eucast.org), all of the strains were sensitive to
ig. 1. Total bioﬁlm biomass of 24-h-old bioﬁlms treated with antibiotics as determined b
elative to treatment with 1% tryptone soya broth (TSB) and reduced by one. Values abov
SB.  Values below 0 are decreases of bioﬁlm biomass. Error bars represent 95% conﬁdenc
ne-way ANOVA (P < 0.05). VAN, vancomycin; TEI, teicoplanin; OXA, oxacillin; RIF, rifamp10% TSB UZ Leuven
the tested antibiotics. The antibiotic sensitivities of the ﬁve other
strains (S. epidermidis 12c, 13c, 16c, 17c and 22c) were determined
by VITEK® 2 analysis (bioMérieux Benelux s.a./n.v., Brussels,
Belgium). These strains were also found to be sensitive to the
selected antibiotics (data not shown).
3.2. Assessment of the effects of antibiotics on in vitro bioﬁlms
To test the effects of the antibiotics on S. epidermidis bioﬁlms,
ﬁve antibiotics with different mechanisms of action were used.
Vancomycin, teicoplanin, oxacillin and rifampicin were selected
because they are the antibiotics of choice for the treatment of
device-related infections with S. epidermidis. The effects of gen-
tamicin were tested as this antibiotic is used in temporary spacers
following the removal of infected prosthetic devices [17]. The
applied concentrations corresponded to the peak serum concen-
trations of the antibiotics [18–20].
Fig. 1 shows the results of CV staining after treatment of 24-h-old
bioﬁlms with the respective antibiotics. Surprisingly, vancomycin
and teicoplanin increased the total bioﬁlm biomass in all of the
tested strains relative to treatment of the bioﬁlms with 1% TSB.
Rifampicin was  the only antibiotic resulting in a decrease of bioﬁlm
biomass produced by S. epidermidis 12c, 13c, 1457 and 22c. Oxacillinomycin and teicoplanin in eradicating and killing Staphylococcus
.doi.org/10.1016/j.ijantimicag.2014.11.011
and gentamicin were marginally effective in reducing the bioﬁlm
biomass.
Fig. 2 shows the bacterial viability after treatment with antibi-
otics as assayed by XTT staining. In contrast to the effect on
y crystal violet staining. For the antibiotic-treated bioﬁlms, the mean A590 is shown
e 0 show increases of the bioﬁlm biomass compared with bioﬁlms treated with 1%
e intervals. * Signiﬁcant difference compared with bioﬁlms treated with 1% TSB by
icin; GEN, gentamicin.
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Fig. 2. Bacterial cell viability of 24-h-old bioﬁlms treated with antibiotics as determined by XTT staining. For the antibiotic-treated bioﬁlms, the mean A490 is shown relative








































co  treatment with 1% tryptone soya broth (TSB) and reduced by one. Values above
alues  below 0 are decreases in bacterial cell viability. Error bars represent 95% con
ne-way ANOVA (P < 0.05). VAN, vancomycin; TEI, teicoplanin; OXA, oxacillin; RIF, 
otal biomass, the effects of the antibiotics on bacterial viability
ere more pronounced. Still, a difference was seen between the
illing activity of the glycopeptides in comparison with the other
ntibiotics. Vancomycin in particular displayed a low potential to
ill bioﬁlm-associated bacteria. Moreover, treatment of bioﬁlms
roduced by S. epidermidis 1457 and 10b signiﬁcantly increased
ioﬁlm-associated viability. Teicoplanin was unable to affect the
acterial viability in bioﬁlms produced by S. epidermidis 1457,
0b and 22c. Most probably these observations are related to the
trong bioﬁlm-producing potential of these strains. Treatment of
he bioﬁlms with the other antibiotics killed a substantial amount
f bioﬁlm-related bacteria, with rifampicin displaying the highest
illing activity (Fig. 2).
SEM was performed after antibiotic treatment of 24-h-old S.
pidermidis 1457 bioﬁlms. Figs. 3 and 4 show SEM images at mag-
iﬁcations of 1000×, 4000× and 10 000×. Although difﬁcult to
uantify, treatment with 40 g/mL vancomycin (Fig. 3C) showed
 slight increase in bioﬁlm accumulation compared with 1% TSB
Fig. 3A). In contrast to this observation, the images could not con-
rm increased bioﬁlm accumulation after treatment with 50 g/mL
eicoplanin (Fig. 3E), even though staining of the bioﬁlms with
V showed an increase in total bioﬁlm biomass, as was  the case
or vancomycin treatment (Fig. 1). Notably, bioﬁlms treated with
he glycopeptides contained damaged bacteria (yellow frames in
ig. 3D and F), whilst these were not visible in non-treated bioﬁlms
Fig. 3B). Treatment with 10 g/mL oxacillin (Fig. 4C and D) resulted
n fewer bacteria, but a matrix or bacterial debris remained attached
o the surface. Treatment with 10 g/mL rifampicin (Fig. 4E and
) visibly decreased the bacterial load and the amount of matrix.
inally, 10 g/mL gentamicin (Fig. 4G and H) did not display a clear
ffect on the bioﬁlm.
.3. Evaluation of the effects of antibiotics combined with
ifampicin on in vitro Staphylococcus epidermidis bioﬁlms
Bioﬁlms produced by S. epidermidis 567, 1457 and 10b were
reated with combinations of antibiotic and rifampicin. Results of
he CV and XTT staining are shown in Figs 5 and 6, respectively.Please cite this article in press as: Claessens J, et al. Inefﬁcacy of vanc
epidermidis bioﬁlms in vitro. Int J Antimicrob Agents (2015), http://dx
he combination of vancomycin or teicoplanin plus rifampicin
ppeared to be signiﬁcantly more effective in reducing the bioﬁlm
iomass (Fig. 5) and bioﬁlm-associated viability (Fig. 6) than van-
omycin or teicoplanin alone. Combining rifampicin with oxacillinw increases in bacterial cell viability compared with bioﬁlm treated with 1% TSB.
e intervals. * Signiﬁcant difference compared with bioﬁlms treated with 1% TSB by
icin; GEN, gentamicin.
or gentamicin did not inﬂuence the activity on the bioﬁlm biomass
(Fig. 5), but for oxacillin the bioﬁlm-associated viability signiﬁ-
cantly decreased in comparison to treatment with oxacillin alone
(Fig. 6).
4. Discussion
Bioﬁlm-related infections are becoming more important in clin-
ical practice with the increasing use of implanted medical devices.
In addition, bacteria growing in a bioﬁlm are characterised by
higher resistance towards antibiotics, as shown by determination
of the bioﬁlm MICs and MBCs as well as MBECs [7]. Therefore,
routine determination of bacterial antibiotic susceptibility during
planktonic growth is not a good prediction for the response of
bioﬁlm-associated bacteria. Until now, methods to evaluate the
effects of antibiotics on bioﬁlms in routine clinical laboratories have
been missing. In this study, CV and XTT staining were used to assess
the effects of antibiotics on S. epidermidis bioﬁlms in vitro. CV is
widely used to evaluate bacterial bioﬁlm formation. However, it
gives no information about the viability of bacteria and the relative
amount of bacteria versus matrix. Thus, we combined CV with XTT
staining to additionally assess bacterial viability [8]. This methodol-
ogy allows evaluation of the bioﬁlm biomass and bacterial viability
separately and has been applied previously. The results of previous
studies showed that bioﬁlm-associated bacteria are less sensitive
to killing by antibiotics compared with their planktonic counter-
parts [8] and that the extracellular matrix remained attached to
the surface, constituting a risk for recolonisation [6,21]. However,
in the present study, we have shown that treatment of bioﬁlms with
vancomycin and teicoplanin increased the total bioﬁlm biomass.
Although SEM images of vancomycin-treated bioﬁlms showed a
small increase in bacterial accumulation (Fig. 3C and D), teicoplanin
did not obviously increase the amount of bioﬁlm-associated bacte-
ria (Fig. 3E and F). Yet both glycopeptides caused visible damage
to the bacteria incorporated in the bioﬁlm. The increased amount
of bioﬁlm-associated bacteria might be an explanation for the
observed rise in the bioﬁlm biomass (Fig. 1).
Assessment of bacterial viability demonstrated a low killingomycin and teicoplanin in eradicating and killing Staphylococcus
.doi.org/10.1016/j.ijantimicag.2014.11.011
efﬁcacy of vancomycin on bioﬁlm-associated S. epidermidis,  even
though the planktonic bacteria were sensitive to vancomycin. The
same observation was made by Monzón et al. [18] who tested
the efﬁcacy of vancomycin on S. epidermidis bioﬁlms by bacterial
ARTICLE IN PRESSG ModelANTAGE-4483; No. of Pages 8



















tig. 3. Scanning electron microscopy images of Staphylococcus epidermidis 1457 bioﬁ
nd  (E and F) 50 g/mL teicoplanin. Images at magniﬁcations of 1000× (left) and 10
iability determination with an ATP bioluminescence assay. The
ower efﬁcacy of vancomycin was attributed to the extracellular
ioﬁlm matrix. Furthermore, Mathur et al. [22] demonstrated that
he MICs and killing efﬁcacies of vancomycin and teicoplanin on
lanktonic S. epidermidis bacteria were negatively inﬂuenced by the
ddition of extracted extracellular bioﬁlm matrix. They hypothe-
ised that the glycopeptides were inactivated by binding matrix
omponents [22]. However, it is often assumed that the extra-
ellular bioﬁlm matrix acts as a physical barrier complicating the
iffusion of antimicrobial agents into the bioﬁlm. The hypothesis
f decreased penetration of vancomycin into the bioﬁlm is con-
radicted by the observation that vancomycin was  present in the
ioﬁlm at concentrations exceeding its MIC  and MBC  values [23].
oth sequestration and decreased penetration could explain thePlease cite this article in press as: Claessens J, et al. Inefﬁcacy of vanc
epidermidis bioﬁlms in vitro. Int J Antimicrob Agents (2015), http://dx
ecreased efﬁcacy of vancomycin observed in the current study.
The results of XTT staining in addition suggested a relation-
hip between the response to treatment with vancomycin and
eicoplanin and the bioﬁlm-producing capacity of the bacterialreated with (A and B) 1% tryptone soya broth (TSB), (C and D) 40 g/mL vancomycin
 (right) are shown. Yellow frames mark groups of damaged bacteria.
strain. S. epidermidis 1457 and 10b, which are better bioﬁlm pro-
ducers than S. epidermidis 567, were less prone to killing by the
glycopeptides. This observation is consistent with the conclusions
made by Antunes et al. [24], who  investigated the MBEC of van-
comycin on bioﬁlms produced by S. epidermidis strains isolated
from CVCs and observed that the stronger bioﬁlm producers dis-
played a higher MBEC [24]. These observations could be explained
by the ‘inoculum effect’, which means that for some antimicro-
bial agents the effectiveness is related to the bacterial cell density
of the inoculum. The antibiotic becomes less effective when the
bacterial cell density of the inoculum is higher because a lower
amount of antibiotic molecules is available per bacterial cell [25].
The relationship between the killing activities of vancomycin and
teicoplanin and the bioﬁlm-producing capacity of the strain is thenomycin and teicoplanin in eradicating and killing Staphylococcus
.doi.org/10.1016/j.ijantimicag.2014.11.011
attributable to a higher bacterial density in bioﬁlms produced by
the ‘strong’ bioﬁlm-producing strains. In addition, teicoplanin was
found to be more effective in killing bioﬁlm-associated bacteria
than vancomycin at peak serum concentrations (Fig. 2).
Please cite this article in press as: Claessens J, et al. Inefﬁcacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus
epidermidis bioﬁlms in vitro. Int J Antimicrob Agents (2015), http://dx.doi.org/10.1016/j.ijantimicag.2014.11.011
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Fig. 4. Scanning electron microscopy images of Staphylococcus epidermidis 1457 bioﬁlms treated with (A and B) 1% tryptone soya broth (TSB), (C and D) 10 g/mL oxacillin,
(E  and F) 10 g/mL rifampicin and (G and H) 10 g/mL gentamicin. Images at magniﬁcations of 4000× (left) and 10 000× (right) are shown.
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Fig. 5. Total bioﬁlm biomass of 24-h-old bioﬁlms of Staphylococcus epidermidis 567, 1457 and 10b treated with antibiotic combinations with rifampicin (RIF) as determined



















boya  broth (TSB). Values above 0.0 show increases in the bioﬁlm biomass, and val
ifference between bioﬁlm biomass after treatment with the antibiotic alone or com
XA,  oxacillin; GEN, gentamicin.
In clinical practice, treatment of foreign body-associated
nfections often consists of a combination of a glycopeptide
ith rifampicin. In vitro assessment of the effects of gly-
opeptide/rifampicin combinations on S. epidermidis bioﬁlms
emonstrated that the increase in total bioﬁlm biomass after treat-
ent of the bioﬁlms with teicoplanin or vancomycin alone was
eutralised (Fig. 5). The killing efﬁcacies of antibiotic combina-
ions with rifampicin were improved compared with the antibioticsPlease cite this article in press as: Claessens J, et al. Inefﬁcacy of vanc
epidermidis bioﬁlms in vitro. Int J Antimicrob Agents (2015), http://dx
lone (Fig. 6). These observations give evidence for the combined
trategy in dealing with bioﬁlm-associated infections. As in the lit-
rature, the in vitro results in the current study advised against the
ombination of rifampicin with gentamicin [26].
ig. 6. Bacterial cell viability of 24-h-old bioﬁlms of Staphylococcus epidermidis 567, 145
y  XTT staining. The bacterial cell viability associated with bioﬁlms treated with antibioti
reated with 1% tryptone soya broth (TSB). Values above 0.0 show increases in the bacte
rror  bars represent 95% conﬁdence intervals. * Signiﬁcant difference between bacterial c
y  one-way ANOVA (P < 0.05). VAN, vancomycin; TEI, teicoplanin; OXA, oxacillin; GEN, ge590
low 0.0 are decreases. Error bars represent 95% conﬁdence intervals. * Signiﬁcant
 with rifampicin by one-way ANOVA (P < 0.05). VAN, vancomycin; TEI, teicoplanin;
The observed inefﬁcacy of vancomycin to kill bioﬁlm-associated
bacteria in vitro may  have consequences in vivo. Indeed, van-
comycin was tested in different animal models of device-related
infections and failed to eradicate the bioﬁlm [27–29]. The con-
centration of vancomycin detected in the bioﬁlms was  above the
MIC  values [29], but only cellular structures were destroyed and
matrix was  left [28]. The remaining material after antibiotic treat-
ment could function as anchorage for other bacteria and encourageomycin and teicoplanin in eradicating and killing Staphylococcus
.doi.org/10.1016/j.ijantimicag.2014.11.011
re-growth of the bioﬁlm and re-colonisation of the device [6].
In accordance with our suggestion that 50 g/mL teicoplanin is
more effective in killing bioﬁlm-associated bacteria than 40 g/mL
vancomycin (Fig. 2), Del Pozo et al. [30] observed the same trend in
7 and 10b treated with antibiotic combinations with rifampicin (RIF) as determined
cs is shown as the mean A490 relative to the bacterial cell viability found in bioﬁlms
rial cell viability after treatment with antibiotics, and values below are decreases.
ell viability after treatment with the antibiotic alone or combined with rifampicin
ntamicin.
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 clinical trial of antibiotic-lock therapy in catheter-related blood-
tream infections.
In conclusion, assessing the effects of antibiotics by CV and XTT
taining plus microscopy showed an increased bioﬁlm biomass and
ecreased killing efﬁcacies of the glycopeptides, in particular van-
omycin, on bioﬁlm-associated bacteria. This might be explained
y the negative impact of the extracellular bioﬁlm matrix on the
iological activity of the glycopeptides Also, an inverse correlation
etween vancomycin susceptibility and bioﬁlm-forming capacity
as found.
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